BY DAN PAGE
UCLA Today
The Department of Neurology ranks No. 1 among
its peers at universities nationwide in National Institutes
of Health (NIH) funding, with $23.4 million in research grants
for 2002, according to newly released figures.
The funding represents a nearly two-fold jump
from $12.3 million the previous year, when the department ranked
No. 8.
John Mazziotta, professor and chair of neurology
at UCLA’s David Geffen School of Medicine, credited the
increase to the widely recognized high caliber and success of
the department’s science.
“The NIH grant review is the toughest
test of peer-reviewed scientific funding. It’s the most
rigorous filter of scientific quality,” Mazziotta said.
“Our funding level shows that UCLA neurology research
has reached new heights in quality and quantity, and now sets
the standard for neurology research nationwide.”
The Department of Neurology accounted for 10%
of all NIH funding in the medical school. The figures do not
include NIH funding obtained by neurology faculty but administered
by the Neuropsychiatric and Brain Research institutes.
The largest current awards within the department
include $7.3 million for the Early Randomized Surgical Epilepsy
Trial led by Jerome Engel, professor and director of the UCLA
Seizure Disorder Center, and $2.5 million for the computational
anatomy and multidimensional modeling project led by Arthur
Toga, professor and director of the UCLA Laboratory of Neuro
Imaging.
Recent scientific breakthroughs by neurology
faculty include: